Kurum Yazarı "Bilici, Ahmet" Bildiri Koleksiyonu İçin Listeleme
-
Clinical importance of discordance in hormone receptor and HER2/NEU status after neoadjuvant chemotherapy in breast cancer
Öven Ustaalioğlu, Bala Başak; Aker Vardar, Fügen; Bilici, Ahmet; Gürleyik, Günay; Erkol, Burçak; Kefeli, Umut (Elsevier, 2014)Aim: Neoadjuvant chemotherapy (NAC) is used longer for both locally advanced breast cancer and early stage to increase breast conservation. Discordance of the hormone receptor (HR) status was reported to be 8-33% of the ... -
Locoregional treatment improves survival in de novo bone-only metastatic breast cancer: Long-term results of the prospective, multi-institutional study - protocol BOMET MF14-01
Soran, Atilla; Doğan, Lütfi; Işık, Arda; Özbaş, Serdar; Can Trabulus, Didem; Demirci, Umut; Karanlık, Hasan; Soyder, Aykut; Dağ, Ahmet; Bilici, Ahmet; Doğan, Mutlu; Şendur, Mehmet Ali Nahit; Köksal, Hande; Gülçelik, Mehmet Ali; Cabıoğlu, Neslihan; Yeniay, Levent; Utkan, Zafer; Karadurmuş, Nuri; Dağlar, Gül; Şimşek, Turgay; Yıldız, Birol; Uras, Cihan; Tükenmez, Mustafa; Özaslan, Cihangir; Maralcan, Göktürk; Kutun, Suat; Karaman, Niyazi; Toktaş, Osman; Yıldırım, Ahmet Özgen; Akçay, Müfide Nuran; Özmen, Vahit; Sezgin, Efe (Springer, 2023)... -
The modified glasgow prognostic score (MGPS) and the mortality prediction MODEL II (MPM II) CAN predict mortality in patients with breast cancer admitted to intensive care: A retrospective cohort study
Ölmez, Ömer Fatih; Tunay, Burcu; Bilici, Ahmet; Bayramgil, Ayberk; Çavuşoğlu, Güneş Dorukhan; Öz, Hüseyin (Lippincott Williams and Wilkins, 2022)... -
Real-life experience with maintenance chemotherapy plus biologics after the first-line treatment of RAS wild-type metastatic colon cancer (mCRC): A multicenter Onco-Colon Turkey study
Artaç, Mehmet; Çubukçu, Erdem; Bozkurt, Oktay; Bilici, Ahmet; Çelik, S.; Özçelik, M.; Öven, B.; Şimşek, E.; Geredeli, C.; Karaca, M.; Cil, T.; Harputluoğlu, Hakan; Şendur, Mehmet Ali Nahit; Türk, H. Mehmet; Kefeli, Umut; Alacacıoğlu, Ahmet; Tural, D.; Sakin, A.; Karadurmuş, Nuri; Çevik, Duygu; Dane, Faysal; Gümüş, Mahmut (Elsevier, 2022)Background: Randomized clinical trials showed that maintenance chemotherapy plus biologics in patients with mCRC could increase the progression free survival (PFS) without any advantage for overall survival (OS). Our aim ... -
The relationship between the change with neoadjuvant chemotherapy in the tumor-infiltrating lymphocyte (TIL) expressions and pathological response in breast cancer patients.
Bilici, Ahmet; Göktaş Aydın, Sabin; Çakır, Aslı; Ölmez, Ömer Fatih; Erol, Vedat Buğra (Lippincott Williams & Wilkins, 2023)... -
Surgical, pathological and clinical features of advanced collorectal cancers with metastasectomy. "Onco-Colon Turkey Registry" real-life data
Karadurmuş, Nuri; Yıldırım, Emre; Yalçın, Şuayib; Gümüş, Mahmut; Bilir, Cemil; Çubukçu, Erdem; Tanrıkulu Şimşek, Eda; Arslan, Çağatay; Dane, Faysal; Çelik, Sinemiş; Bilici, Ahmet; Şendur, Mehmet Ali Nahit; Öven, Başak Bala; Işıkdoğan, Abdurrahman; Türk, Hacı Mehmet; Karaca, Mustafa; Karabulut, Bülent; Özçelik, Melike; Çevik, Duygu; Kefeli, Umut (Lippincott Williams & Wilkins, 2022)Background: The contribution of metastasectomy to progression-free survival (PFS) and overall survival (OS) in patients (pts) with advanced stage colorectal cancer has been demonstrated in clinical trials. However, clinical ...